Sherry A. Glied (
Stuart H. Altman is a professor of national health policy at the Heller School for Social Policy and Management, Brandeis University, in Waltham, Massachusetts.
Health Aff (Millwood). 2017 Sep 1;36(9):1572-1577. doi: 10.1377/hlthaff.2017.0555.
The United States relies on competition to balance costs and quality in the health care system. But concentration is increasing throughout the hospital, physician, and insurer markets. Midsize community hospitals face declining demand and growing competition from both larger hospitals and smaller freestanding diagnostic and surgical centers, leaving the midsize hospitals vulnerable to closure or merger with other facilities. Competition among insurers has been limited by the development of hospital systems that extend the bargaining power of "must-have" hospitals (those perceived to provide the best care for complex and less common conditions) across local health care markets. Government antitrust enforcement could play an important role in maintaining competition in both the hospital and insurer markets, but in many markets, the impact of that enforcement has been limited to date. Policy makers should consider supplementing antitrust activities with strategies that combine competition and regulation-for example, by regulating selected prices and structuring competition to cover entire insurance markets.
美国依赖竞争来平衡医疗体系中的成本和质量。但在医院、医生和保险公司市场,集中程度正在不断提高。中型社区医院面临需求下降和来自大型医院以及小型独立诊断和外科中心的竞争加剧,这使得中型医院容易关闭或与其他设施合并。保险公司之间的竞争受到限制,原因是医院系统的发展扩大了“必须拥有”医院(那些被认为对复杂和罕见疾病提供最佳护理的医院)在当地医疗保健市场的议价能力。政府反垄断执法可以在维持医院和保险公司市场竞争方面发挥重要作用,但迄今为止,这一执法的影响在许多市场上受到限制。政策制定者应该考虑在反垄断活动中加入结合竞争和监管的策略,例如,通过监管选定的价格和构建涵盖整个保险市场的竞争。